- Home
- AISPW vs TNGX Comparison
AISPW vs TNGX Comparison
Compare AISPW & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AISPW
- TNGX
- Stock Information
- Founded
- AISPW N/A
- TNGX 2014
- Country
- AISPW United States
- TNGX United States
- Employees
- AISPW 51
- TNGX N/A
- Industry
- AISPW Blank Checks
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- AISPW Finance
- TNGX Health Care
- Exchange
- AISPW Nasdaq
- TNGX Nasdaq
- Market Cap
- AISPW N/A
- TNGX 735.0M
- IPO Year
- AISPW 2021
- TNGX N/A
- Fundamental
- Price
- AISPW $0.20
- TNGX $7.15
- Analyst Decision
- AISPW
- TNGX Strong Buy
- Analyst Count
- AISPW 0
- TNGX 8
- Target Price
- AISPW N/A
- TNGX $15.14
- AVG Volume (30 Days)
- AISPW N/A
- TNGX 902.1K
- Earning Date
- AISPW N/A
- TNGX 11-06-2024
- Dividend Yield
- AISPW N/A
- TNGX N/A
- EPS Growth
- AISPW N/A
- TNGX N/A
- EPS
- AISPW N/A
- TNGX N/A
- Revenue
- AISPW N/A
- TNGX $42,509,000.00
- Revenue This Year
- AISPW N/A
- TNGX $18.15
- Revenue Next Year
- AISPW N/A
- TNGX N/A
- P/E Ratio
- AISPW N/A
- TNGX N/A
- Revenue Growth
- AISPW N/A
- TNGX 26.16
- 52 Week Low
- AISPW N/A
- TNGX $6.33
- 52 Week High
- AISPW N/A
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- AISPW N/A
- TNGX 42.73
- Support Level
- AISPW N/A
- TNGX $6.83
- Resistance Level
- AISPW N/A
- TNGX $7.47
- Average True Range (ATR)
- AISPW 0.00
- TNGX 0.35
- MACD
- AISPW 0.00
- TNGX 0.14
- Stochastic Oscillator
- AISPW 0.00
- TNGX 72.25
About AISPW Airship AI Holdings Inc.
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.